Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
MetaStat Inc
MTSTCurrent price
0.0005 USD
0 USD (0.00%)
Last closed
0.0005 USD
Company
www.metastat.com
ISIN
US59140A2033
Sector
Healthcare
Industry
Biotechnology
Exchange
PINK
Capitalization
20 571 USD
Yield for 12 month
+400.00 %
1Y
3Y
5Y
10Y
15Y
MTST
MetaStat, Inc., a precision medicine company, focuses on discovering and developing therapeutic and diagnostic treatment solutions for cancer patients. The company is developing novel drug candidates and companion diagnostic tests that target the MENA pathway. Its product candidates include MENA diagnostic assay, a tissue-based quantitative immunofluorescence test that measures expression of the pro-metastatic MENA protein splice-variant; companion diagnostic to predict RTK inhibitor drug responses and anti-microtubule drug responses; liquid blood-based biopsy to enhance cancer diagnosis and optimize patient care; MetaSite Breast assay, an immunohistochemistry test that measures micro-anatomical intravasat at blood vessels within the tumor microenvironment ion sites; and prognostic diagnostic to predict risk of cancer metastasis. The company's therapeutic targets a critical metastatic pathway in solid tumors responsible for driving tumor resistance and the spread of aggressive cancer. MetaStat, Inc. is based in Boston, Massachusetts. Address: 27 Drydock Avenue, Boston, MA, United States, 02210
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
18.45 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
–
Last Year
–
Current Quarter
-344 079 USD
Last Quarter
-400 084 USD
Key Figures MTST
1 year
3 years
5 years
10 years
EBITDA
-3 461 274 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-222.86 %
PEG Ratio
–
Return On Equity TTM
–
Wall Street Target Price
18.45 USD
Revenue TTM
23 300 USD
Book Value
-0.26 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
-1 233 214 USD
Earnings per share
-0.09 USD
Diluted Eps TTM
-0.09 USD
Most Recent Quarter
I 2018
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics MTST
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History MTST
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:15
Payout Ratio
–
Last Split Date
08.10.2015
Dividend Date
–
Stock Valuation MTST
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
30.2002
Price Sales TTM
0.8829
Enterprise Value EBITDA
-0.2367
Price Book MRQ
–
Financials MTST
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators MTST
For 52 weeks
0.0001 USD
0.0005 USD
50 Day MA
0.0002 USD
Shares Short Prior Month
–
200 Day MA
0.0001 USD
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart